![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 49, 47692-47700, December 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
andFrom the Department of Biochemistry and Cell Biology and the Institute for Cell and Developmental Biology, State University of New York at Stony Brook, Stony Brook, New York 11794-5215
Received for publication, August 8, 2002, and in revised form, September 30, 2002
| |
ABSTRACT |
|---|
|
|
|---|
In the yeast, Saccharomyces
cerevisiae, oligosaccharyl transferase (OT) is composed of nine
different transmembrane proteins. Using a glycosylatable peptide
containing a photoprobe, we previously found that only one essential
subunit, Ost1p, was specifically labeled by the photoprobe and recently
have shown that it does not contain the recognition domain for the
glycosylatable sequence Asn-Xaa-Thr/Ser. In this study we utilized
additional glycosylatable peptides containing two photoreactive groups
and found that these were linked to Stt3p and Ost3p. Stt3p is the most
conserved subunit in the OT complex, and therefore 21 block mutants in
the lumenal region were prepared. Of the 14 lethal mutant proteins only
two, as well as one temperature-sensitive mutant protein, were
incorporated into the OT complex. However, using microsomes prepared
from these three strains, the labeling of Ost1p was markedly decreased
upon photoactivation with the Asn-Bpa-Thr photoprobe. Based on the block mutants single amino acid mutations were prepared and analyzed. From all of these results, we conclude that the sequence from residues
516 to 520, WWDYG in Stt3p, plays a central role in glycosylatable peptide recognition and/or the catalytic glycosylation process.
Oligosaccharyl transferase
(OT)1 transfers preassembled
oligosaccharide chains from a lipid-linked oligosaccharide donor
(Dol-PP-GlcNAc2Man9Glc3) onto
asparagine residues specified by the Asn-Xaa-Thr/Ser sequence, where
Xaa can be any amino acid except proline (1-6). Biochemical, molecular
biological, and genetic studies have led to the identification of a
remarkably large number of subunits for yeast OT (7-20). During the
last decade, OT complexes have been purified from different sources,
such as dog pancreas (21, 22), hen oviduct (23), human (24) and pig
liver (25), and yeast (10, 26, 27).
To identify the subunit(s) of yeast OT that recognizes Asn-Xaa-Thr/Ser
sites that can be glycosylated, earlier we developed a photoaffinity
probe containing a photoreactive benzophenone derivative,
p-benzoylphenylalanine (Bpa) (28). By using this 125I-labeled Bpa-containing tripeptide, we found that Ost1p
was specifically labeled by photoactivation in yeast microsomes (29).
However, subsequently we found that Ost1p is not the glycosylation site recognition/catalytic
subunit.2
In this study, we used additional sets of peptides containing two
photoreactive groups for photoactivation and found that the photoprobes
became linked to Stt3p. Stt3p is highly conserved in eukaryotes and
essential for vegetative growth of yeast cells. In fact, it is the most
conserved subunit among the OT components. Human, murine, and
Drosophila proteins, as well as a putative protein in
Caenorhabditis elegans, are more than 50% identical in
amino acid sequence (17). Stt3p contains a very hydrophobic N-terminal
domain spanning the membrane 10-12 times and a hydrophilic, lumenal
domain at the C terminus (16, 17).
To further investigate function of Stt3p, we prepared 21 block mutants
in the lumenal domain within regions of high conservation. Furthermore,
single amino acid mutations that were derived from the block mutants
were also prepared. Based on studies with these and other mutants, we
conclude that Stt3p is the OT subunit involved in peptide recognition
and/or catalysis and that the sequence at residues 516-520, WWDYG,
plays a key role in this process.
Strains and Plasmids--
W303-1a (MAT a ade2
can1 his3 leu2 trp1 ura3) was used as the parental strain to
generate the Stt3p hemagglutinin (HA) construct that is integrated into
the chromosome. PCR was carried out using the ME-3 plasmid (which
contains a triple HA tag and the his5+ gene from
Schizosaccharomyces pombe) as the template. The primers were
5'-TCTACGAAAACCAGAAGGTCCATAAAGAGACCTGAATTAGGCTTGAGAGTCTACCCATACGATGTTCCT-3' and
5'-ACCAAAAAGGGCAAAGACGATCCGTCACGAGCGATCATAATAACGGGAAGGGAAGTCGACGGTATCGATAAG-3'. A linear PCR product was used to transform W303-1a by homologous recombination. The resulting transformant was designated as QYY697. The
diploid strain W303 (ade2 can1 his3 leu2 trp1 ura3) was used to generate QYY698 (ade2 can1 his3 leu2 trp1 ura3
STT3/
YEp352-STT3 was obtained from the laboratory of Dr. Markus
Aebi. A 2.9-kb fragment was generated by PCR using QYY697 genomic DNA
as template and 5'-CCAAGCTTATGG GATCCGACCGGTCGTGTG-3' and 5'-CCGAGCTCCTGCAGCCCGGGGGATCCAC-3' as primers. The resulting
PCR product was subcloned into pRS314, which was digested with
SmaI and SacI to generate the plasmid
pRS314-STT3HA.
Materials--
Asn-Bpa-Thr-Am was custom-made by Quality
Controlled Biochemicals (Hopkinton, MA), and
Bpa-Ala-Asn-Ala-Thr-Ala-Bpa-Am and Asn-Bpa-Thr-Ala-Bpa-Am were
custom-made by Center for the Analysis and Synthesis of
Macromolecules (Stony Brook, NY). In each case the N terminus
was derivatized with 125I-labeled Bolton-Hunter (bh)
reagent (3 Ci/µmol; ICN, Irvine, CA) as described previously (30),
yielding 125I-bh-Asn-Bpa-Thr-Am,
125I-bh-Bpa-Ala-Asn-Ala-Thr-Ala-Bpa-Am, and
125I-bh-Asn-Bpa-Thr-Ala-Bpa-Am, respectively.
[3H]Acetic anhydride (7.3 Ci/µmol; Amersham
Biosciences) was used to prepare [3H]Ac-Asn-Bpa-Thr-Am
(31). Yeast microsomes were prepared as described by Baker et
al. (32).
PCR Mutagenesis--
PCR mutagenesis was performed according to
the manufacturer's protocol (Stratagene, La Jolla, CA). For all of the
group and single-residue mutations mentioned in this paper,
pRS314-STT3HA was used as the template. Mutagenized plasmids
were sequenced, and those with the expected sequence were transformed
into QYY700. The transformants were selected for Trp and Ura
prototrophy and then further for 5-fluro-orotic acid selection.
Conditions for Photoactivation and
Immunoprecipitation--
Yeast spheroplasts or crude microsomes were
used for photolysis as described previously (29). After irradiation,
immunoprecipitation was performed as described by Karaoglu et
al. (33), except that after the photoactivation step the reaction
was adjusted to 1.5% digitonin, 0.5 M NaCl, 20 mM Tris·Cl, pH 7.4, 3.5 mM MgCl2.
The solution was centrifuged for 20 min at 55,000 rpm in a TLA
100.3 rotor (Beckman, Fullerton, CA), and the supernatant fraction was used for immunoprecipitation.
Spotting Assay for Growth--
To determine the growth
difference between yeast cells carrying stt3p mutants, the same
amount of cells (5 × 106) were collected after the
strains had been grown to early log phase in Oligosaccharyl Transferase Activity Assay--
To determine
whether in fact 125I-bh-Bpa-Ala-Asn-Ala-Thr-Ala-Bpa-Am and
125I-bh-Asn-Bpa-Thr-Ala-Bpa-Am are substrates for OT, yeast
microsomes (50 µg of total protein/reaction) were used for the assay.
The assay was performed as described (34). To determine the OT activity of the stt3p mutants, yeast spheroplasts were prepared from each mutant
and [3H]Ac-Asn-Bpa-Thr-Am was used as the substrate. For
each reaction, 50 µl of spheroplasts (equivalent to 5 A600 units of cells) and 0.5 µCi of peptide
substrate were used. After incubation at 25 °C for 20 min, the
entire reaction was added to concanavalin A-agarose beads. After
allowing glycosylated peptides to bind at room temperature for 4 h, concanavalin A beads were washed twice with 50 mM
Tris·Cl, pH 7.4, 1 mM MnCl2, 1 mM
MgCl2, 1 mM CaCl2, 1% Nonidet
P-40. The amount of the radioactivity on the beads was counted.
Endoglycosidase H Digestion--
For the immunoprecipitated
samples, the proteins were eluted from protein G-agarose beads with
0.5% SDS and 1% Quantitation of Immunoprecipitated OT Subunits and Radiolabeled
Ost1p--
Quantitation of immunoprecipitated OT subunits and
radiolabeled Ost1p was performed by scanning the films and analyzing
the bands using the NIH Image 1.62 program. For the block mutants, we
used the same volume of microsomes as the control for
immunoprecipitation and photoactivation. We normalized the amount of
protein immunoprecipitated and radiolabeled Ost1p to the wild type
control. For the point mutants, we used the same volume of microsomes
as the control for immunoprecipitation. After quantifying the Ost1p in
these microsomes, we used an amount of microsomes that precipitated an
equivalent amount of Ost1p for photoactivation.
Additional OT Subunits Can Be Photolabeled Using Probes Other
than Asn-Bpa-Thr--
Previously we used
125I-bh-Asn-Bpa-Thr-Am for photoactivation. It is known
that the OT does not have a specific requirement for the middle amino
acid, as long as it is not proline, which would introduce a rigid kink
in the conformation of the peptide (1, 2). Although Bpa is located
between Asn and Thr, the benzoyl side chain could be oriented away from
the enzyme active site. Because we found that a tripeptide with Bpa in
the middle position did not lead to photolabeling of the active
site,2 we synthesized and tested peptides in which Bpa was
located at different positions. We blocked the N termini of the
peptides with the 125I-Bolton-Hunter reagent and blocked
the C termini with amide bonds.
First, we prepared a heptapeptide (Table
I, peptide II) in which two Bpa residues
were incorporated with the hope that the photoprobe could act as a
bifunctional probe and thereby cross-link two different proteins (or
two different parts of the same protein). This peptide was found to be
a substrate for OT, although it was not as effective as the original
tripeptide (data not shown).
In a second experiment we studied this peptide in terms of
photolabeling of OT subunits upon incubation with microsomes. After photoactivation, the microsomes were solubilized with digitonin, and
the clarified supernatant was used for nondenaturing
immunoprecipitation. Microsomes from a strain containing a
chromosomally integrated HA epitope-tagged form of the OST3
gene were used to do photolabeling with this heptapeptide. The proteins
precipitated with anti-HA antibodies were fractionated on SDS-PAGE and
subjected to autoradiography. This photoprobe labeled two proteins of
the OT complex (Fig. 1a, lanes 2 and 3). Based on the molecular mass, the
upper radiolabeled band could be either Ost1p or Stt3p, and the lower
band could be Ost3p. Although the calculated molecular mass for
Stt3p is 78 kDa, it was found that it migrates anomalously (runs
between 60 and 70 kDa) and always as a diffuse band, and therefore it is hard to separate Ost1p from Stt3p (33, 35). To clarify these issues,
we used microsomes prepared from strains
that expressed either Ost1HAp or Stt3HAp for photolabeling experiments.
The triple HA tag has a mass about 3 kDa, and we can detect the
migration change by adding it to the C terminus of either Ost1p or
Stt3p. When using microsomes prepared from the OST1HA
strain, the upper radiolabeled band did not change its mobility,
whereas the lower band increased its mobility. In comparison, when
microsomes from an STT3HA containing strain were used, the
upper radiolabeled band decreased its mobility, whereas the lower band
migrated as it did in the OST1HA construct. These results
clearly established that the upper radiolabeled band was Stt3p and that
the lower radiolabeled band was Ost3p. It seems that when
epitope-tagged Ost3p was replaced by the other epitope-tagged subunits
for immunoprecipitation, less Ost3p was precipitated (lanes
1 and 4). Similar results were obtained by Karaoglu
et al. (33).
This heptapeptide was designed to be a bifunctional photoprobe with the
hope that it could cross-link two nearby OT subunits. Based on our
results this obviously was not the case. If this peptide cross-linked
two proteins together, we should detect a radiolabeled band that
migrated at a position equal to the sum of the two polypeptides. We
conclude that the photoprobe is acting as a monofunctional probe,
although there are two photoreactive groups available. Because the
excitation time of the photoprobe is short (0.8-1.2 µs in the
presence of a suitably oriented C-H bond) (28), it is unlikely that
two photoreactive groups would be excited at the same time. The excited
state readily relaxes to the ground state if it does not encounter a
hydrogen donor with the appropriate geometry. Once one Bpa is
cross-linked to one protein, the other one might not be positioned
optimally for photolyzing and linking to another protein.
We also prepared a pentapeptide bifunctional photoprobe in which one of
the Bpa residues was placed between Asn and Thr, the same position as
in the original tripeptide (Table I, peptide I), and another Bpa was
located at the C terminus (Table I, peptide III). This peptide was
found to be a good substrate for OT. Microsomes from an
OST3HA strain were used for photoactivation followed by nondenaturing immunoprecipitation. Three radiolabeled bands were detected on the autoradiogram (Fig. 1b, lane 3).
Based on the molecular mass and the characteristics of the bands, we
assumed that they were Stt3p, Ost1p, and Ost3p. This was confirmed by using microsomes prepared from OST1HA and STT3HA
strains for photoactivation. When using Ost1HAp microsomes for
photoactivation, the upper band (Stt3p) did not change its mobility
compared with using the Ost3HAp microsomes. But the middle band
(Ost1HAp) decreased its mobility because of the addition of the triple
HA tag, and the lower band increased its mobility because it no longer
had a triple HA tag (Ost3p) (Fig. 1b, lane 1).
Similarly, when using Stt3HAp microsomes for photoactivation, the upper
band (Stt3HAp) migrated more slowly compared with using the Ost3HAp
microsomes, whereas the lower band (Ost3p) migrated more quickly, and
the middle band (Ost1p) did not change its mobility (Fig.
1b, lane 5). To better distinguish Stt3p from
Ost1p, we performed Endo H digestion of the immunoprecipitated samples.
Both Ost1p and Stt3p are glycosylated proteins, and after deglycosylation Ost1p was readily distinguished from Stt3p (Fig. 1b, lanes 2, 4, and 6). By
comparing lanes 2, 4, and 6, it is clear that these three radiolabeled bands are Stt3p, Ost1p, and Ost3p.
It is obvious that this pentapeptide also did not act as a bifunctional
photoprobe, that is, it did not label any two polypeptides simultaneously. However, the fact that it became linked to Ost1p was
consistent with the photolabeling of Ost1p when the tripeptide was used
because one of the two Bpa residues in the pentapeptide is located in
the position between Asn and Thr. It is of interest that the probe with
Bpa at the C terminus of the pentapeptide labeled two different
proteins. We speculate that this Bpa is probably located at the
interface of Stt3p and Ost3p. These two subunits are likely to be near
to each other because it is well established that they exist in one
subcomplex (Ost3p-Ost4p-Stt3p) (33, 35, 36). It is not surprising that
Bpa could label both Stt3p and Ost3p because the photoreactive group is
free to rotate.
Block Mutations of Stt3p--
From the previous results it is
clear that both Stt3p and Ost3p are in the vicinity of Ost1p in the OT
complex. This conclusion is supported by the observation that upon
depletion of Stt3p, both Ost1p and Ost3p disappear from the purified OT
complex, whereas Wbp1p and Swp1p are still present (17). Because Stt3p
is the most conserved subunit of OT complex, it is reasonable to
speculate that it contains the recognition element and/or catalytic
domain for glycosylation. Ost3p is not an essential subunit and thus is
not likely to carry out a function absolutely required for glycosylation.
The subunit that contains the recognition element and/or catalytic
domain for glycosylation must be essential, and mutations in the
recognition element and/or catalytic domain would be expected to cause
lethality or a severe growth defect. However, if the mutant protein
does not get incorporated into the OT complex, we cannot determine
whether it is a functional mutation. If it does get incorporated and if
the mutation is not lethal, the OT activity would be expected to be
dramatically decreased in the mutant. Most importantly, the mutant
would be expected to cause a marked decrease in the labeling of Ost1p
by the tripeptide Asn-Bpa-Thr. We asked whether Stt3p meets all of
these criteria. A search for homologous proteins in the data bases
showed that yeast Stt3p shares high homology with proteins in human,
mouse, Drosophila, and C. elegans (greater than
50% identity over a region of 700 amino acid residues). It even shares
homology with a protein in archaebacteria (35). It is remarkable that
the identity shared among these proteins is not restricted to one
region but rather is spread out over the entire polypeptide. Sequence
analysis also demonstrated that the secondary structure predicted for
these homologous proteins is quite similar (17).
Fig. 2 illustrates the very high
conservation of the lumenal domains of Stt3p among different species.
It is well established that the active site of OT is located in the ER
lumen, and for this reason we focused our attention on the lumenal
domain of Stt3p in the ER (37). First, on the basis of high
conservation, we prepared 21 block mutants consisting of 2-5 residues
replaced by Ala residues in an epitope-tagged Stt3p construct (Table
II). These mutants were transformed into
an stt3 null strain containing wild type STT3 on a URA3 plasmid. First, we used
the plasmid shuffling procedure to ask whether these Ala mutations
caused loss of function in these mutant stt3p. Out of the 21 mutants,
six of them properly functioned and were not further studied. Of the
remainder, 14 mutants were lethal, and one mutant was
temperature-sensitive (Table II). Next, we determined which of these
block mutant proteins were incorporated into the OT complex in cells
because, as noted above, mutants that do not make stable proteins or
proteins that cannot be incorporated into the OT complex are of very
limited value. It is important to note that the 14 lethal mutants also contain the wild type STT3 gene to support the growth, but
the temperature-sensitive mutant contained only the mutant stt3p. All
of the mutant constructs and the wild type control construct of Stt3p
contained the HA tag at their C terminus. Detergent extracts were used
for immunoprecipitation with anti-HA antibodies, and the precipitated
proteins were fractionated on SDS-PAGE and then followed by Western
blot analysis. Using the antibodies available to us, we found that
mutants 516-519AAAA, 592-594AAA, and 554-556AAA were assembled into
the OT complex and co-immunoprecipitated other OT subunits, including
Ost1p, Wbp1p, and Swp1p (Fig. 3). For
the temperature-sensitive mutant 554-556AAA, the mutant protein was incorporated into the OT complex at both 25 and 37 °C. Of the remainder, some stt3 proteins were not immunoprecipitated
well themselves, and others did not co-immunoprecipitate other OT
subunits; these mutants were not further studied.
These three block mutants (516-519AAAA, 592-594AAA, and 554-556AAA)
cannot function in the cells even though they are incorporated in the
OT complex. It is very interesting that one of the three block mutants,
516-519WWDY, is in a region that shares the highest sequence
similarity among eukaryotic Stt3p and the archaeal proteins (35) (Fig.
2). Actually, almost all residues of 516-520WWDYG are conserved
in all the archaebacteria proteins (Initially, Gly520 was
not included in this block mutation because it was known that G520D and
G520S were temperature-sensitive mutants, but later the G520D mutant
was included when preparing other point mutants based on the block
mutations). It seems reasonable to presume that this level of identity
reflects functional importance.
In our earlier study,2 it was shown that although when
using the Asn-Bpa-Thr tripeptide for photolabeling Ost1p was
specifically labeled, this subunit did not contain the peptide
glycosylation recognition and/or catalytic domain. Stt3p is in the
proximity to Ost1p and is the most conserved subunit of OT. Therefore,
if particular residues in Stt3p are involved in glycosylation site recognition and/or the catalytic site, mutation of these residues should abolish labeling of Ost1p by Asn-Bpa-Thr. Microsomes were prepared from these three stt3 block mutants, and
photolabeling was carried out using radiolabeled Asn-Bpa-Thr. The
results clearly demonstrated that mutant 516-519AAAA
and mutant 592-594AAA had drastically
reduced labeling of Ost1p (0.115 and 0.200 compared with the wild type
control), whereas mutant 554-556AAA had a level of labeling one half
of the wild type (Fig. 4, a
and b, and Table III). We
speculate that 516-520WWDYG forms the binding region for the
glycosylation recognition site or serves as the active site of the
enzyme. Clearly, when these residues are mutated, Asn-Bpa-Thr cannot be
recognized or cannot be positioned at the correct site for
glycosylation, and therefore the photolabeling of Ost1p is greatly
reduced. The residues 554-556EEK and 592-594RIS are probably not
within the active site but instead may be involved in positioning the
active site of the enzyme. When they are mutated, a modified enzyme
conformation might reduce the binding of the substrate, and therefore
the photolabeling of Ost1p would be greatly reduced.
Single Amino Acid Mutations of Stt3p--
Because these three
block mutants had important characteristics, we undertook to prepare 10 single amino acid mutants in which each residue was replaced either by
Ala or by Asp in an epitope-tagged STT3 construct (Table
IV). Five mutants derived from changes of the most conserved region, 516-520WWDYG, displayed the most severe growth defects. Two mutations caused lethality, and the other three
were temperature-sensitive. Three point mutations derived from the
temperature-sensitive block mutant 554-556EEK caused no growth
phenotype, and we did not pursue additional studies with them. As to
the block mutant 592-594RIS, we prepared only two single mutations;
Ser594 was not included because this residue is not highly
conserved. Although I593D was a temperature-sensitive mutant, R592A had
no growth phenotype, and it was not studied further.
We performed a spotting assay to analyze the growth phenotype of the
four temperature-sensitive mutants. As shown in Fig. 5, the growth rate for these cells was
wild type > Y519A > G520D > I593D > W516A.
Next, we examined the incorporation of the six single-residue mutant
proteins into the OT complex. The two lethal mutants also contained the
wild type STT3 gene to support the growth, but the
temperature-sensitive mutants had only their own copy of
stt3. All of the mutant constructs and the wild type control contained the HA tag at their C terminus for immunoprecipitation and
could co-immunoprecipitate other OT subunits except G520D (part of the
data are shown in Fig. 6 below, also see
Table IV). Protein made from the G520D construct was comparable in
amount with the wild type, but it could not co-immunoprecipitate other OT subunits well. Interestingly, in genetic screens aimed at the identification of components required for the process of
N-linked glycosylation in the ER, Markus Aebi's group
identified more than 50 stt3 alleles, and four of those had
a temperature-sensitive phenotype (35). Surprisingly, three of the four
mutations affected the same amino acid residue, which was
Gly520; two of these were G520D, and one was G520S.
Although these single-residue mutants are incorporated into the OT
complex, we wanted to determine whether they could support the
photolabeling of Ost1p when using the Asn-Bpa-Thr photoprobe for
photoactivation. All of the temperature-sensitive mutants had lower
Ost1p photolabeling. Of the two lethal mutants, W517A and D518A
exhibited residual labeling of Ost1p (Fig. 4c and Table IV).
These findings support the observations shown earlier with the
corresponding block mutant and the idea that 516-520WWDYG may form the
recognition and/or catalytic site for glycosylation. Among these five
residues, Trp517 and Asp518 are most important
because mutation of these two caused lethality. When Trp517
and Asp518 were mutated, the cells could not survive
without a copy of the wild type gene, and there was only a low level of
Ost1p labeling.
Residues 516-520WWDYG may well function as the catalytic site rather
than merely as the recognition site to which Asn-Xaa-Thr/Ser binds. In
the two mechanisms proposed earlier for the OT enzymatic reaction (see
below), there is a base in the enzyme active site that extracts a
proton from either Asn or Thr, thus increasing the nucleophilicity of
the carboxamide nitrogen so it can react with the electrophilic
lipid-linked oligosaccharide. In this case, Asp518, with
the Asp fully ionized, is a perfect candidate for such a base in the
enzyme active site.
In addition to changing these residues to Ala or Asp, we also changed
these residues to somewhat similar residues (Table II). W517Y and D518E
were still lethal mutations, and W516Y was temperature-sensitive as
well. Therefore, an aromatic ring is not sufficient at position 516 or
517, and the enzyme probably requires the hydrophobicity of the Trp.
Trp often serves as a hydrophobic cluster in the conformational properties of proteins, and mutation of this residue could perturb the
original conformation (38-40). Surprisingly, Glu518 could
not replace the Asp at all; the extra CH2 renders it
nonfunctional. This further demonstrates the importance of this Asp,
because it is not only the negative charge but also the chain length
that is important. These findings suggest that Asp518 could
be in the catalytic site.
We also measured the OT activity of these single-residue mutants. We
could not directly assay the lethal mutants because they have a wild
type copy of STT3. First, the expression of Ost1p, Wbp1p,
and CPY was examined in the temperature-sensitive mutants because it
has been shown that these proteins are glycosylated (Fig. 6). Ost1p
contains four potential glycosylation sites, and usually three or four
sites are utilized (11, 26). Wbp1p contains two potential glycosylation
sites, and one or two are glycosylated (7, 26). In mature CPY all four
glycosylation sites should be occupied (41). It is clear that the
proteins detected by their corresponding antibodies migrated as
ladders. These ladders are the different glycoforms of the proteins
because they all shifted to one band after deglycosylation with
protein glycanase F or Endo H (data not shown for Ost1p and
Wbp1p). It is obvious that Ost1p, Wbp1p, and CPY were underglycosylated
in the mutant cells.
In addition, direct in vitro OT activity assays were
performed on the single-residue temperature-sensitive mutants. Compared with the wild type control, extracts prepared from the stt3
mutants displayed much lower OT activity (Table IV). This result
correlates well with the in vivo underglycosylation of the
glycoproteins in these mutants. Clearly, these residues are important
in the function of OT, and therefore we investigated their apparent
affinity for the substrates. As shown in Fig.
7, the level of glycosylated peptide
formation was dependent on the substrate concentration. However, at low
substrate concentrations, the extracts from the mutant strains
exhibited much less product formation when compared with the extract
from the wild type strain. Only at high substrate concentrations were
the glycosylated products formed in the mutants comparable with the
amount formed in the control. Because we had a limited quantity of the
radiolabeled substrates, we could not perform OT assays using even
higher substrate concentrations. But based on the data obtained these
mutant proteins may have a higher Km for the peptide
substrates.
Conclusions--
OT catalyzes the formation of an N-C bond
between the amide nitrogen of the asparagine side chain and the C1
position of the N-acetylglucosamine residue of the
Dol-PP-oligosaccharide. Although Dol-PP is a reasonable leaving group,
it is not clear how the nucleophilicity of the asparagine side chain is
enhanced so that it can displace Dol-PP and form the
N-glycosidic bond. Besides the asparagine residue, the
requirement for a hydroxyl amino acid implies a direct role for the
hydroxyl group in catalysis. Bause and Legler (42) proposed a mechanism
in which the hydroxyl group of the serine or threonine in the peptide
acts as a hydrogen acceptor, with one of the carboxamide hydrogen atoms
of the asparagine side chain as the donor. This is proposed to occur
because a basic residue at the enzyme active site abstracts a proton
from the hydroxyl group of serine or threonine, and this, in turn
removes a proton from the amide. The resulting strong nucleophile would then displace the dolichol pyrophosphate from the C1 position of the
N-acetylglucosamine containing oligosaccharide.
Besides its consensus sequence requirements, it seems that conformation
of the peptides is important because many Asn-Xaa-Thr/Ser sequences are
not glycosylated following translation and translocation into the ER
lumen (2, 43). The conformation that the Asn-Xaa-Thr sequence can adopt
can be either the
The involvement of the Asx turn in the glycosylation reaction proposed
by Imperiali is supported by the observation that cyclized peptides
that can adopt the Asx turn are good substrates of OT (45, 46). Given
these findings and the results on Stt3p presented in this paper, and on
Ost1p,3 we propose that the
nascent polypeptides that are being elongated pass by Stt3p, and if
they contain an Asn-Xaa-Thr/Ser (with an Asx turn), they fit into a
cleft in Stt3p. This is shown in the diagram in Fig.
8, which summarizes the labeling observed
with the three different photoprobes. This cleft is proposed to
represent the recognition domain that would contact the backbone of the substrate only when it is in the Asx turn conformation. The sequence WWDYG in Stt3p is either part of the recognition domain to contact the
Asx turn or it could be part of the active site. If it is the latter
case, it must be in close physical proximity to the glycosylation site
recognition domain of Stt3p, thereby allowing the ionized form of D (we
found that the longer side chain E is not functional), in conjunction
with a base, to extract a proton from the amide side chain. In this way
the amide could function as a nucleophile in the attack on the
Dol-PP-oligosaccharide. In the Asx turn, the photoreactive side chain
of Bpa in the Xaa position would be oriented outward, and it therefore
would label the nearby protein Ost1p rather than Stt3p.
In contrast, when a heptapeptide with Bpa at two positions distal to
Asn-Xaa-Thr/Ser is used, both Stt3p and Ost3p are labeled (Table I and
Fig. 8). Finally, when a pentapeptide with Bpa at one of these distal
locations and one located at the Xaa position are used, Ost1p, Ost3p,
and Stt3p are labeled. These observations are internally consistent
with an Asx turn extending into a cleft where the recognition and/or
active sites of Stt3p are located, and the more distal portions of the
substrate are in close opposition to Ost1p and Ost3p. This model is
also consistent with the observation that down-regulation of Stt3p
leads to a loss of Ost1p and Ost3p in the purified OT complex (17).
Finally, this model is supported by the recent unpublished
observation3 that Ost1p and Stt3p can be chemically
cross-linked to each other. Clearly, these models for the action of
Stt3p in the glycosylation process are based on a variety of
observations from various experiments in different laboratories. Only
when it is possible to obtain the three-dimensional structures of these
proteins of the OT complex will it be possible to test the validity of them.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
stt3::his 5+ (S. pombe)).
PCR was carried out using the ME-3 plasmid as the template. The primers
were
5'-CGGTCTAATTCAACGTGACATAGCATCCGCAATCGCATTCACAGCCGTAAATCCCCCCGGGCTGCAGGAATTC-3' and
5'-ACCAAAAAGGGCAAAGACGATCCGTCACGAGCGATCATAATAACGGGAAGGGAAGTCGACGGTATCGATAAG-3'. A linear PCR product was used to transform the W303 diploid
strain by homologous recombination. The resulting transformant was
designated as QYY698. QYY698 was transformed with
YEp352-STT3 and sporulated. The haploid strain QYY700 (MAT
a ade2 can1 his3 leu2 trp1 ura3
stt3::his5+ (S. pombe)
YEp352-STT3) was selected on
His
Ura (media) plates. All
of the mutant strains were generated using QYY700 as the parental strain.
Trp media at 25 °C.
Then 10 µl of serial 1:10 dilutions of the cells were spotted on
Trp plates and incubated at 25, 30, and 37 °C, respectively.
-mercaptoethanol after immunoprecipitation and
subjected to Endo H digestion as suggested by the manufacturer (New
England Biolabs, Beverly, MA). For CPY Western blot analysis, 25 µl
of spheroplasts (equivalent to 2.5 A600 units of
cells) were centrifuged, and the pellets were resuspended with 0.5%
SDS and 1%
-mercaptoethanol. The suspension was boiled for 10 min
and centrifuged. The supernatant was subjected to Endo H digestion as
suggested by the manufacturer.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
Differential labeling of OT subunits by three different photoprobes

View larger version (40K):
[in a new window]
Fig. 1.
Photolabeling of OT subunits using
bifunctional photoprobes. Microsomes were prepared from each
epitope-tagged strain, and photoactivation was carried out. Photolyzed
microsomes were subjected to immunoprecipitation as described under
"Experimental Procedures." The samples were analyzed by SDS-PAGE,
and the labeled peptides were detected by autoradiography. The
arrows indicate the positions of the corresponding
radiolabeled proteins. The numbers in parentheses
indicate the lanes in which particular OT subunits are
located. a, heptapeptide was used for photoactivation.
b, pentapeptide was used for photoactivation. After elution
of each sample from the immunoprecipitate, one half of the sample was
directly applied to SDS-PAGE (lanes 1, 3, and
5), whereas the other half was subjected to Endo H digestion
(lanes 2, 4, and 6).

View larger version (84K):
[in a new window]
Fig. 2.
Sequence alignment of the C-terminal lumenal
domain of Stt3p. The identification of the human,
Drosophila, and C. elegans Stt3p was
obtained using BLAST version 2.0. Alignments were performed using the
Macvector program. The identical amino acids are boxed and
shaded, whereas the conservative replacements are only
boxed. The identity was over 50%. Gaps are indicated
by dashes.
Growth phenotype of stt3p block and point mutants

View larger version (43K):
[in a new window]
Fig. 3.
Stt3p mutants 516-519AAAA, 592-594AAA, and
554-556AAA are integrated into the OT complex. Microsomes were
prepared from each mutant strain and the wild type strain.
Nondenaturing immunoprecipitation was carried out using mouse anti-HA
antibody as described under "Experimental Procedures." Equal
amounts of each sample that had been eluted from protein G-agarose
beads were analyzed on SDS-PAGE, followed by Western blot analysis
using anti-rabbit HA, anti-Ost1p, anti-Wbp1p, or anti-Swp1p
antibodies as indicated.

View larger version (14K):
[in a new window]
Fig. 4.
Photolabeling of Ost1p in the strains
carrying Stt3p block mutants and point mutants. Microsomes were
prepared from each stt3p mutant strain that contains the HA epitope-tag
at the C terminus, and photolabeling was carried out using
125I-bh-Asn-Bpa-Thr-Am. Photolyzed microsomes were
subjected to immunoprecipitation as described under "Experimental
Procedures." The samples were analyzed by SDS-PAGE, and the labeled
peptides were detected by autoradiography. a, two lethal
block mutants and wild type control. b, one
temperature-sensitive mutant and wild type control. c, two
lethal point mutants and wild type control.
Characteristics of the stt3 block mutants
Characteristics of point mutants

View larger version (35K):
[in a new window]
Fig. 5.
Spotting growth assay of Stt3p single amino
acid mutant strains. Comparison of growth phenotype of strains
carrying point mutations in Stt3p at the indicated amino acid
positions. Cultures of wild type control and mutant strains were
diluted serially and spotted on plates. After 2 days the growth of
colonies at three different temperatures was compared.

View larger version (57K):
[in a new window]
Fig. 6.
Temperature-sensitive stt3
point mutations cause glycosylation defects. In a
and b, microsomes were prepared from each mutant strain and
the wild type control. Nondenaturing immunoprecipitation was carried
out as described under "Experimental Procedures." The samples
eluted from protein G-agarose beads were resolved by SDS-PAGE and
followed by Western blot analysis using anti-Ost1p and anti-Wbp1p,
respectively. In c, spheroplasts were prepared from each
mutant strain and the wild type control. Endo H digestion was performed
using these spheroplasts as described under "Experimental
Procedures." The samples were separated on SDS-PAGE and followed by
Western blot analysis using anti-CPY antibody. The numbers
next to the protein bands indicate estimates of the number of
oligosaccharide chains on the protein.

View larger version (20K):
[in a new window]
Fig. 7.
Assay of the temperature-sensitive mutants of
Stt3p for OT activity. Yeast spheroplasts were prepared from each
mutant, and [3H]Ac-Asn-Bpa-Thr-Am was used as the
substrate. The reaction was carried out as described under
"Experimental Procedures." In each reaction, the amount of
spheroplasts was the same, and the concentration of the radiolabeled
peptide varied. Each point on the plots is the average of duplicates.
This assay was performed three separate times, and all assays yielded
similar plots.
-turn or the Asx turn. The
-turn is
characterized by a hydrogen bond between the threonine amide and the
carbonyl immediately preceding the asparagine. As pointed out by
Imperiali and Shannon (44), the Asx turn involves a hydrogen bond
between the carboxamide oxygen of asparagine and the backbone amide and
the side chain hydroxyl of threonine or serine, which both act as
hydrogen donors. When synthetic cyclic peptides were tested it was
found that peptides constrained into
-turns are not substrates for
OT, whereas peptides with Asx turn conformations have enhanced affinity
for the enzyme (45). Accordingly, Imperiali et al. (46, 47)
proposed a model in which the basic residue at the active site of the
enzyme abstracts a proton from the
-nitrogen and subsequently
induces tautomerization of the carboxamide to an imidol. This imidol
can act as a reactive nucleophile for displacement of the dolichol
pyrophosphate from the electrophilic dolichol-linked oligosaccharide
donor to yield the glycosylated product and dolichol pyrophosphate.
This model provides a structural explanation for the sequence
specificity of the acceptor substrates, because sequences such as
Gln-Xaa-(Thr/Ser) cannot serve as oligosaccharide acceptors because
they cannot adopt an analogous Gln turn conformation. In both models,
the presence of an active site base is a central element because
deprotonation is essential for the formation of a competent
nucleophilic species.

View larger version (15K):
[in a new window]
Fig. 8.
Highly diagrammatic representation of the
labeling observed with the three photoprobes. The proteins that
became labeled are shown in the boxes. Except in the
case of Ost1p, we do not know which Bpa residue at the distal positions
labeled Stt3p or Ost3p in panel B. A,
125I-bh-Asn-Bpa-Thr-Am. B,
125I-bh-Bpa-Ala-Asn-Ala-Thr-Ala-Bpa-Am. C,
125I-bh-Asn-Bpa-Thr-Ala-Bpa-Am.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Markus Aebi for generous gifts of YEp352-STT3 plasmid and anti-Wbp1p and anti-Swp1p antibodies, Dr. Reid Gilmore for anti-Ost1p antibody, and Dr. Satoshi Yoshida for anti-Stt3p antibody. We give special thanks to Drs. Robert Haltiwanger, Ann Sutton, Hangil Park, Tadashi Suzuki, and Elizabeth Till for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant GM33185.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Dept. of Molecular Biology, The Scripps Research
Inst., 10550 N. Torrey Pines Rd., MEM-L71, La Jolla, CA 92037
§ To whom correspondence should be addressed. Tel.: 631-632-8560; Fax: 631-632-8575; E-mail: wlennarz@notes.cc.sunysb.edu.
Published, JBC Papers in Press, September 30, 2002, DOI 10.1074/jbc.M208136200
2 Yan, Q., and Lennarz, W. J. (2002) Proc. Natl. Acad. Sci. U.S.A., in press.
3 A. Yan and W. J. Lennarz, unpublished observations.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: OT, oligosaccharyl transferase; Dol, dolichol; Bpa, p-benzoylphenylalanine; HA, hemagglutinin; bh, Bolton-Hunter reagent; Am, amide; Endo H, endoglycosidase H; CPY, carboxypeptidase Y.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Marshall, R. D. (1972) Annu. Rev. Biochem. 41, 673-702[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Gavel, Y.,
and von Heijne, G.
(1990)
Protein Eng.
3,
433-442 |
| 3. | Herscovics, A., and Orlean, P. (1993) FASEB J. 7, 540-550[Abstract] |
| 4. | Silberstein, S., and Gilmore, R. (1996) FASEB J. 10, 849-858[Abstract] |
| 5. | Knauer, R., and Lehle, L. (1999) Biochim. Biophys. Acta 1426, 259-273[Medline] [Order article via Infotrieve] |
| 6. | Yan, Q., and Lennarz, W. J. (1999) Biochem. Biophys. Res. Commun. 266, 684-689[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | te Heesen, S., Rauhut, R., Aebersold, R., Abelson, J., Aebi, M., and Clark, M. W. (1991) Eur. J. Cell Biol. 56, 8-18[Medline] [Order article via Infotrieve] |
| 8. | te Heesen, S., Janetzky, B., Lehle, L., and Aebi, M. (1992) EMBO J. 11, 2071-2075[Medline] [Order article via Infotrieve] |
| 9. | te Heesen, S., Knauer, R., Lehle, L., and Aebi, M. (1993) EMBO J. 12, 279-284[Medline] [Order article via Infotrieve] |
| 10. | Knauer, R., and Lehle, L. (1994) FEBS Lett. 344, 83-86[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Silberstein, S.,
Collins, P. G.,
Kelleher, D. J.,
Rapiejko, P. J.,
and Gilmore, R.
(1995)
J. Cell Biol.
128,
525-536 |
| 12. | Pathak, R., Parker, C. S., and Imperiali, B. (1995) FEBS Lett. 362, 229-234[CrossRef][Medline] [Order article via Infotrieve] |
| 13. |
Silberstein, S.,
Collins, P. G.,
Kelleher, D. J.,
and Gilmore, R.
(1995)
J. Cell Biol.
131,
371-383 |
| 14. |
Karaoglu, D.,
Kelleher, D. J.,
and Gilmore, R.
(1995)
J. Cell Biol.
130,
567-577 |
| 15. | Yoshida, S., Ikeda, E., Uno, I., and Mitsuzawa, H. (1992) Mol. Gen. Genet. 231, 337-344[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Yoshida, S., Ohya, Y., Nakano, A., and Anraku, Y. (1995) Gene (Amst.) 164, 167-172[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Zufferey, R., Knauer, R., Burda, P., Stagljar, I., te Heesen, S., Lehle, L., and Aebi, M. (1995) EMBO J. 14, 4949-4960[Medline] [Order article via Infotrieve] |
| 18. |
Chi, J. H.,
Roos, J.,
and Dean, N.
(1996)
J. Biol. Chem.
271,
3132-3140 |
| 19. | Reiss, G., te Heesen, S., Gilmore, R., Zufferey, R., and Aebi, M. (1997) EMBO J. 16, 1164-1172[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Knauer, R.,
and Lehle, L.
(1999)
J. Biol. Chem.
274,
17249-17256 |
| 21. | Kelleher, D. J., Kreibich, G., and Gilmore, R. (1992) Cell 69, 55-65[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Kelleher, D. J.,
and Gilmore, R.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4994-4999 |
| 23. |
Kumar, V.,
Heinemann, F. S.,
and Ozols, J.
(1994)
J. Biol. Chem.
269,
13451-13457 |
| 24. | Kumar, V., Korza, G., Heinemann, F. S., and Ozols, J. (1995) Arch. Biochem. Biophys. 320, 217-223[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Breuer, W., and Bause, E. (1995) Eur. J. Biochem. 228, 689-696[Medline] [Order article via Infotrieve] |
| 26. |
Kelleher, D. J.,
and Gilmore, R.
(1994)
J. Biol. Chem.
269,
12908-12917 |
| 27. | Pathak, R., Hendrickson, T. L., and Imperiali, B. (1995) Biochemistry 34, 4179-4185[CrossRef][Medline] [Order article via Infotrieve] |
| 28. | Dorman, G., and Prestwich, G. D. (1994) Biochemistry 33, 5661-5673[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Yan, Q.,
Prestwich, G. D.,
and Lennarz, W. J.
(1999)
J. Biol. Chem.
274,
5021-5025 |
| 30. | Welply, J. K., Kaplan, H. A., Shenbagamurthi, P., Naider, F., and Lennarz, W. J. (1986) Arch. Biochem. Biophys. 246, 808-819[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Welply, J. K.,
Shenbagamurthi, P.,
Naider, F.,
Park, H. R.,
and Lennarz, W. J.
(1985)
J. Biol. Chem.
260,
6459-6465 |
| 32. |
Baker, D.,
Wuestehube, L.,
Schekman, R.,
Botstein, D.,
and Segev, N.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
355-359 |
| 33. |
Karaoglu, D.,
Kelleher, D. J.,
and Gilmore, R.
(1997)
J. Biol. Chem.
272,
32513-32520 |
| 34. |
Roos, J.,
Sternglanz, R.,
and Lennarz, W. J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
1485-1489 |
| 35. | Spirig, U., Glavas, M., Bodmer, D., Reiss, G., Burda, P., Lippuner, V., te Heesen, S., and Aebi, M. (1997) Mol. Gen. Genet. 256, 628-637[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Kim, H.,
Park, H.,
Montalvo, L.,
and Lennarz, W. J.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
1516-1520 |
| 37. |
Nilsson, I. M.,
and von Heijne, G.
(1993)
J. Biol. Chem.
268,
5798-5801 |
| 38. | Evans, P. A., Topping, K. D., Woolfson, D. N., and Dobson, C. M. (1991) Proteins 9, 248-266[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Baldwin, R. L.
(2002)
Science
295,
1657-1658 |
| 40. |
Klein-Seetharaman, J.,
Oikawa, M.,
Grimshaw, S. B.,
Wirmer, J.,
Duchardt, E.,
Ueda, T.,
Imoto, T.,
Smith, L. J.,
Dobson, C. M.,
and Schwalbe, H.
(2002)
Science
295,
1719-1722 |
| 41. | Stevens, T., Esmon, B., and Schekman, R. (1982) Cell 30, 439-448[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Bause, E., and Legler, G. (1981) Biochem. J. 195, 639-644[Medline] [Order article via Infotrieve] |
| 43. |
Pless, D. D.,
and Lennarz, W. J.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
134-138 |
| 44. | Imperiali, B., and Shannon, K. L. (1991) Biochemistry 30, 4374-4380[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Imperiali, B., Shannon, K. L., and Rickert, K. W. (1992) J. Am. Chem. Soc. 114, 7942-7944 |
| 46. | Imperiali, B., Shannon, K. L., Unno, M., and Rickert, K. W. (1992) J. Am. Chem. Soc. 114, 7944-7945 |
| 47. | Imperiali, B., and Hendrickson, T. L. (1995) Bioorgan. Med. Chem. 3, 1565-1578[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
C. M. Wilson, Q. Roebuck, and S. High Ribophorin I regulates substrate delivery to the oligosaccharyltransferase core PNAS, July 15, 2008; 105(28): 9534 - 9539. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kohda, M. Yamada, M. Igura, J. Kamishikiryo, and K. Maenaka New oligosaccharyltransferase assay method Glycobiology, November 1, 2007; 17(11): 1175 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Kelleher, S. Banerjee, A. J. Cura, J. Samuelson, and R. Gilmore Dolichol-linked oligosaccharide selection by the oligosaccharyltransferase in protist and fungal organisms J. Cell Biol., April 9, 2007; 177(1): 29 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Wilson and S. High Ribophorin I acts as a substrate-specific facilitator of N-glycosylation J. Cell Sci., February 15, 2007; 120(4): 648 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Castro, F. Movsichoff, and A. J. Parodi Preferential transfer of the complete glycan is determined by the oligosaccharyltransferase complex and not by the catalytic subunit PNAS, October 3, 2006; 103(40): 14756 - 14760. [Abstract] [Full Text] [PDF] |
||||
![]() |